254 related articles for article (PubMed ID: 16474940)
41. Experimental study of the efficacy of linezolid alone and in combinations against experimental meningitis due to Staphylococcus aureus strains with decreased susceptibility to beta-lactams and glycopeptides.
Cabellos C; Garrigós C; Taberner F; Force E; Pachón-Ibañez ME
J Infect Chemother; 2014 Sep; 20(9):563-8. PubMed ID: 24973908
[TBL] [Abstract][Full Text] [Related]
42. Treatment of prosthetic valve infective endocarditis due to multi-resistant Gram-positive bacteria with linezolid.
Wareham DW; Abbas H; Karcher AM; Das SS
J Infect; 2006 Apr; 52(4):300-4. PubMed ID: 16099052
[TBL] [Abstract][Full Text] [Related]
43. Coagulase-negative staphylococcal meningitis in adults: clinical characteristics and therapeutic outcomes.
Huang CR; Lu CH; Wu JJ; Chang HW; Chien CC; Lei CB; Chang WN
Infection; 2005 Apr; 33(2):56-60. PubMed ID: 15827871
[TBL] [Abstract][Full Text] [Related]
44. Prophylactic efficacy of linezolid alone or combined with levofloxacin and vancomycin in a rat subcutaneous pouch model of graft infection caused by Staphylococcus epidermidis with intermediate resistance to glycopeptides.
Giacometti A; Ghiselli R; Cirioni O; Mocchegiani F; Orlando F; Del Prete MS; D'Amato G; Silvestri C; Saba V; Scalise G
J Antimicrob Chemother; 2003 Oct; 52(4):724-6. PubMed ID: 12951347
[TBL] [Abstract][Full Text] [Related]
45. Detection of vancomycin heteroresistant Staphylococcus haemolyticus and vancomycin intermediate resistant Staphylococcus epidermidis by means of vancomycin screening agar.
Chiew YF; Charles M; Johnstone MC; Thompson KM; Parnell KD; Penno EC
Pathology; 2007 Jun; 39(3):375-7. PubMed ID: 17558874
[No Abstract] [Full Text] [Related]
46. Randomized non-inferiority trial to compare trimethoprim/sulfamethoxazole plus rifampicin versus linezolid for the treatment of MRSA infection.
Harbarth S; von Dach E; Pagani L; Macedo-Vinas M; Huttner B; Olearo F; Emonet S; Uçkay I
J Antimicrob Chemother; 2015 Jan; 70(1):264-72. PubMed ID: 25209610
[TBL] [Abstract][Full Text] [Related]
47. Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility.
Howden BP; Ward PB; Charles PG; Korman TM; Fuller A; du Cros P; Grabsch EA; Roberts SA; Robson J; Read K; Bak N; Hurley J; Johnson PD; Morris AJ; Mayall BC; Grayson ML
Clin Infect Dis; 2004 Feb; 38(4):521-8. PubMed ID: 14765345
[TBL] [Abstract][Full Text] [Related]
48. Linezolid versus vancomycin for meticillin-resistant Staphylococcus aureus infection: a meta-analysis of randomised controlled trials.
An MM; Shen H; Zhang JD; Xu GT; Jiang YY
Int J Antimicrob Agents; 2013 May; 41(5):426-33. PubMed ID: 23537580
[TBL] [Abstract][Full Text] [Related]
49. Clinical outcomes by methicillin-resistant Staphylococcus aureus staphylococcal cassette chromosome mec type: isolates recovered from a phase IV clinical trial of linezolid and vancomycin for complicated skin and skin structure infections.
Huang DB; Reisman A; Hogan P
Antimicrob Agents Chemother; 2010 Sep; 54(9):4036-7. PubMed ID: 20585131
[No Abstract] [Full Text] [Related]
50. Linezolid treatment of prosthetic hip Infections due to methicillin-resistant Staphylococcus aureus (MRSA).
Bassetti M; Di Biagio A; Cenderello G; Del Bono V; Palermo A; Cruciani M; Bassetti D
J Infect; 2001 Aug; 43(2):148-9. PubMed ID: 11676523
[TBL] [Abstract][Full Text] [Related]
51. Successful treatment of methicillin-resistant Staphylococcus aureus pulmonary infection with linezolid in a patient with cystic fibrosis.
Ferrin M; Zuckerman JB; Meagher A; Blumberg EA
Pediatr Pulmonol; 2002 Mar; 33(3):221-3. PubMed ID: 11836802
[TBL] [Abstract][Full Text] [Related]
52. Efficacy of linezolid plus rifampin in an experimental model of methicillin-susceptible Staphylococcus aureus endocarditis.
Dailey CF; Pagano PJ; Buchanan LV; Paquette JA; Haas JV; Gibson JK
Antimicrob Agents Chemother; 2003 Aug; 47(8):2655-8. PubMed ID: 12878535
[TBL] [Abstract][Full Text] [Related]
53. Treatment of meningitis caused by vancomycin-resistant Enterococcus faecium: high-dose and combination daptomycin therapy.
Le J; Bookstaver PB; Rudisill CN; Hashem MG; Iqbal R; James CL; Sakoulas G
Ann Pharmacother; 2010 Dec; 44(12):2001-6. PubMed ID: 21119097
[TBL] [Abstract][Full Text] [Related]
54. Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan.
Kohno S; Yamaguchi K; Aikawa N; Sumiyama Y; Odagiri S; Aoki N; Niki Y; Watanabe S; Furue M; Ito T; Croos-Dabrera R; Tack KJ
J Antimicrob Chemother; 2007 Dec; 60(6):1361-9. PubMed ID: 17913720
[TBL] [Abstract][Full Text] [Related]
55. In vivo efficacy of continuous infusion versus intermittent dosing of linezolid compared to vancomycin in a methicillin-resistant Staphylococcus aureus rabbit endocarditis model.
Jacqueline C; Batard E; Perez L; Boutoille D; Hamel A; Caillon J; Kergueris MF; Potel G; Bugnon D
Antimicrob Agents Chemother; 2002 Dec; 46(12):3706-11. PubMed ID: 12435665
[TBL] [Abstract][Full Text] [Related]
56. Penetration of fusidic acid and rifampicin into cerebrospinal fluid in low-grade inflammatory meningitis caused by Staphylococcus epidermidis.
Hedberg A; Hårdemark HG; Olsson-Liljequist B; Sjölin J
Clin Microbiol Infect; 2004 Aug; 10(8):765-8. PubMed ID: 15301684
[TBL] [Abstract][Full Text] [Related]
57. A case of community-onset meningitis caused by hospital methicillin-resistant Staphylococcus aureus successfully treated with linezolid and rifampicin.
Al Kandari M; Jamal W; Udo EE; El Sayed A; Al Shammri S; Rotimi VO
Med Princ Pract; 2010; 19(3):235-9. PubMed ID: 20357511
[TBL] [Abstract][Full Text] [Related]
58. Vancomycin-resistant Enterococcus faecium meningitis successfully managed with linezolid: case report and review of the literature.
Zeana C; Kubin CJ; Della-Latta P; Hammer SM
Clin Infect Dis; 2001 Aug; 33(4):477-82. PubMed ID: 11462183
[TBL] [Abstract][Full Text] [Related]
59. Efficacy of linezolid in treatment of experimental endocarditis caused by methicillin-resistant Staphylococcus aureus.
Dailey CF; Dileto-Fang CL; Buchanan LV; Oramas-Shirey MP; Batts DH; Ford CW; Gibson JK
Antimicrob Agents Chemother; 2001 Aug; 45(8):2304-8. PubMed ID: 11451689
[TBL] [Abstract][Full Text] [Related]
60. Linezolid alone or combined with rifampin against methicillin-resistant Staphylococcus aureus in experimental foreign-body infection.
Baldoni D; Haschke M; Rajacic Z; Zimmerli W; Trampuz A
Antimicrob Agents Chemother; 2009 Mar; 53(3):1142-8. PubMed ID: 19075065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
